Focus: Globus Medical is a public medical device company specializing in minimally-invasive surgical tools for spinal and musculoskeletal procedures. The company generated $1.6B in revenue in FY 2025, positioning it as a scaled player in the orthopedic device market.
Profile data last refreshed 10h ago · AI intelligence enriched 1w ago
Hot — 781 jobs added in 30d
Net +700 (781 new, 81 removed). Aggressive expansion phase.
Best suited for device engineers, commercial professionals, and clinical ops roles; less attractive for traditional pharma scientists or drug developers.
Help build intelligence for Globus Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Globus Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Here's Why You Should Retain AMN Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain AMN Stock in Your Portfolio for Now TradingView
Novocure Reports Patient Data Exposure in Cybersecurity Incident - TradingView
Novocure Reports Patient Data Exposure in Cybersecurity Incident TradingView
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now - TradingView
Here's Why You Should Retain Cencora Stock in Your Portfolio for Now TradingView
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - TradingView
Reasons to Hold HealthEquity Stock in Your Portfolio for Now TradingView
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC - TradingView
Philips Shares AI Tool Data for Mitral Regurgitation Assessment at ESC TradingView
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - TradingView
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now TradingView
Showing 6 of 10 news items
Based on last 4 crawl cycles
Source: USCIS H-1B Employer Data Hub
Recent peer-reviewed publications with author affiliations at this company
Safety of Transcranial Motor-Evoked Potential Linked Quadripolar Montage.
Biomechanical comparison of triangular osteosynthesis and triangular minimally invasive spinopelvic stabilization technique for pelvic fragility fractures.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo